OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid · OpenFeds · OpenSpending

© 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodology•Download Data
  1. Home
  2. Providers
  3. Vikas Malhotra
🎗️
MDIndividual

Vikas Malhotra, M.D.

NPI: 1821058496
Spring Hill, FL
10 years of data
Hematology-Oncology
$52.8M
Total Payments
691
Beneficiaries
5.9M
Services
3.39x
Markup Ratio

Peer Comparison

99th
percentile in specialty
This provider$52.8M
Specialty median$339.6K
Rank #10 of 60 in specialty

📋 Key Findings

1Billed $52.8M over 10 years
23.39x markup ratio (above median)
399th percentile in Hematology-Oncology by payments
42.3K services/day — physically implausible
59 procedures with >3x markup

⚠️ This provider averages 2.3K services per working day — physically unusual for an individual practitioner

Based on 5.9M total services over 10 years (250 working days/year). Learn about impossible service volumes →

🔎 Data Analysis

This provider's $52.8M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.

Averaging 2.3K services per working day raises questions about billing patterns.

AI-generated analysis based on Medicare payment data.

Annual Medicare Payments

Annual Services Provided

Avg Payment per Service

Markup Ratio Over Time

Submitted Charges vs. Medicare Payments

Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.

YearAvg SubmittedAvg PaidMarkup RatioGap per ServiceTotal PaymentsServicesBeneficiaries
2014$30.04$8.583.50x$21.46$7.6M888.4K81
2015$33.22$10.003.32x$23.22$8.3M830.6K84
2016$30.29$8.783.45x$21.51$5.8M663.8K80
2017$33.20$10.143.27x$23.06$5.4M537.0K73
2018$29.09$8.333.49x$20.76$4.7M562.3K72
2019$27.02$8.473.19x$18.55$6.0M710.6K72
2020$35.89$10.803.32x$25.09$4.5M412.7K64
2021$35.13$10.353.39x$24.78$3.8M366.9K64
2022$24.56$6.853.59x$17.71$3.4M498.9K59
2023$28.89$8.193.53x$20.70$3.3M397.0K42

Top Procedures (20)

J9271Injection, pembrolizumab, 1 mg⚠ 3.1x markup
$8.0M
192.8K services$41.28/svc3.10x markup
J9035Injection, bevacizumab, 10 mg
$4.8M
84.8K services$56.17/svc2.72x markup
J9299Injection, nivolumab, 1 mg⚠ 3.1x markup
$4.2M
198.4K services$21.27/svc3.12x markup
J9310Injection, rituximab, 100 mg
$3.2M
5.2K services$603.56/svc2.53x markup
J0897Injection, denosumab, 1 mg
$2.2M
149.3K services$15.03/svc2.79x markup
78815Nuclear medicine study with ct imaging skull base to mid-thigh⚠ 4.3x markup
$2.1M
2.6K services$803.78/svc4.30x markup
J2505Injection, pegfilgrastim, 6 mg
$2.0M
640 services$3.1K/svc2.55x markup
99214Established patient office or other outpatient visit, 30-39 minutes⚠ 3.2x markup
$1.9M
21.8K services$85.88/svc3.22x markup
J9041Injection, bortezomib (velcade), 0.1 mg
$1.8M
49.9K services$35.95/svc2.66x markup
J0885Injection, epoetin alfa, (for non-esrd use), 1000 units
$1.8M
195.4K services$8.98/svc2.66x markup
96413Administration of chemotherapy into vein, 1 hour or less⚠ 3.9x markup
$1.5M
14.7K services$104.37/svc3.89x markup
J9395Injection, fulvestrant, 25 mg
$1.4M
19.3K services$72.22/svc2.85x markup
J1569Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg⚠ 3.0x markup
$1.3M
38.2K services$34.33/svc3.01x markup
J9305Injection, pemetrexed, 10 mg
$1.2M
24.5K services$47.52/svc2.61x markup
J9355Injection, trastuzumab, 10 mg
$885.0K
13.0K services$68.05/svc2.38x markup
J9999Not otherwise classified, antineoplastic drugs⚠ 3.6x markup
$852.1K
24.0K services$35.53/svc3.57x markup
A9552Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
$770.8K
2.1K services$366.33/svc1.70x markup
J1442Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
$759.5K
973.1K services$0.78/svc2.56x markup
J9025Injection, azacitidine, 1 mg⚠ 5.1x markup
$753.1K
315.0K services$2.39/svc5.14x markup
J9264Injection, paclitaxel protein-bound particles, 1 mg⚠ 3.0x markup
$749.9K
94.0K services$7.98/svc3.01x markup
Show detailed table ▾
CodeDescriptionServicesPaymentsAvg/ServiceMarkup
J9271Injection, pembrolizumab, 1 mg192.8K$8.0M$41.283.10x
J9035Injection, bevacizumab, 10 mg84.8K$4.8M$56.172.72x
J9299Injection, nivolumab, 1 mg198.4K$4.2M$21.273.12x
J9310Injection, rituximab, 100 mg5.2K$3.2M$603.562.53x
J0897Injection, denosumab, 1 mg149.3K$2.2M$15.032.79x
78815Nuclear medicine study with ct imaging skull base to mid-thigh2.6K$2.1M$803.784.30x
J2505Injection, pegfilgrastim, 6 mg640$2.0M$3.1K2.55x
99214Established patient office or other outpatient visit, 30-39 minutes21.8K$1.9M$85.883.22x
J9041Injection, bortezomib (velcade), 0.1 mg49.9K$1.8M$35.952.66x
J0885Injection, epoetin alfa, (for non-esrd use), 1000 units195.4K$1.8M$8.982.66x
96413Administration of chemotherapy into vein, 1 hour or less14.7K$1.5M$104.373.89x
J9395Injection, fulvestrant, 25 mg19.3K$1.4M$72.222.85x
J1569Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg38.2K$1.3M$34.333.01x
J9305Injection, pemetrexed, 10 mg24.5K$1.2M$47.522.61x
J9355Injection, trastuzumab, 10 mg13.0K$885.0K$68.052.38x
J9999Not otherwise classified, antineoplastic drugs24.0K$852.1K$35.533.57x
A9552Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries2.1K$770.8K$366.331.70x
J1442Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram973.1K$759.5K$0.782.56x
J9025Injection, azacitidine, 1 mg315.0K$753.1K$2.395.14x
J9264Injection, paclitaxel protein-bound particles, 1 mg94.0K$749.9K$7.983.01x

Markup Analysis

Charge-to-Payment Ratio

3.39x

This provider submits charges 3.39 times higher than what Medicare actually pays.

What This Means

A markup ratio of 3.39x means for every $100 Medicare pays, this provider initially charges $339. This is higher than the national average.

Location

Spring Hill, FL

Provider Verification

Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.

Similar Providers

Other Hematology-Oncology providers in FL for peer comparison.

Vikas Malhotra (you)
$52.8M
Christopher Lobo, MD⚠️
$60.5M
Maen Hussein, M.D.
$57.6M
Andrew Lipman, M.D.⚠️
$51.1M
Syed Zafar, M.D.⚠️
$48.1M
Rebecca Kosloff, MD
$47.1M
Show detailed table ▾
ProviderLocationTotal PaymentsStatus
Christopher Lobo, MDPort Charlotte, FL$60.5M⚠️ Flagged
Maen Hussein, M.D.Tavares, FL$57.6M✓ Clear
Andrew Lipman, M.D.Naples, FL$51.1M⚠️ Flagged
Syed Zafar, M.D.Fort Myers, FL$48.1M⚠️ Flagged
Rebecca Kosloff, MDBonita Springs, FL$47.1M✓ Clear

Related

Browse
← Back to Provider Directory
State
All providers in FL →
Specialty
All Hematology-Oncology providers →
Tool
Compare this provider →
Analysis
Fraud Watchlist →
Search
Search all providers →

Share This Provider

Share this provider's Medicare payment information

Share:

Data Sources

  • • Centers for Medicare & Medicaid Services (CMS)
  • • Medicare Provider Utilization and Payment Data (2014-2023)
  • • National Plan and Provider Enumeration System (NPPES)

Last Updated: February 2026 (data through 2023, the latest CMS release)

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.

Believe this data is inaccurate? Dispute this data